The Clinical Effects of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients with Chronic
Zhaoshuang Zhong1, Long Zhao1, Kaiming Chen2
1Department of Respiratory, Central Hospital, Shenyang Medical College, Shenyang, China.
Insights
Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) does not significantly reduce major adverse cardiac events in patients with chronic total occlusion (CTO) lesions. Further high-quality trials are needed to confirm these findings.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Imaging
Background:
- The clinical efficacy of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) lesions is not well-established.
- Angiography-guided PCI is the current standard, but its limitations in complex lesions like CTOs warrant investigation into alternative guidance methods.
Purpose of the Study:
- To conduct a meta-analysis comparing the clinical outcomes of IVUS-guided CTO-PCI versus angiography-guided CTO-PCI.
- To evaluate the impact of IVUS guidance on major adverse cardiac events (MACE) and other key clinical endpoints in CTO interventions.
Main Methods:
- A systematic literature search was performed across major databases (PubMed, Embase, Cochrane Library, ISI Web of Science) up to November 2021.
- Five studies comprising 2320 patients were included, comparing IVUS-guided PCI with angiography-guided PCI for CTO lesions.
- Key endpoints analyzed included MACE, cardiac death, all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR).
Main Results:
- The meta-analysis found no statistically significant reduction in MACE (RR 0.929, P=0.457) with IVUS-guided PCI compared to angiography-guided PCI.
- Similarly, no significant differences were observed for cardiac death (RR 0.574, P=0.096), all-cause death (RR 0.677, P=0.158), MI (RR 0.836, P=0.482), or TVR (RR 0.929, P=0.648).
- The heterogeneity among studies for MACE and MI was low to moderate (I²=27.4% and 46.7%, respectively).
Conclusions:
- IVUS-guided PCI does not offer significant advantages over angiography-guided PCI in terms of MACE and other major adverse cardiac events for patients with CTO lesions.
- The current evidence suggests that IVUS guidance may not improve procedural outcomes in this specific patient population.
- Further high-quality randomized controlled trials (RCTs) are recommended to definitively ascertain the role of IVUS in CTO interventions, considering the limitations of the existing studies.
Background:
The clinical effects of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) lesions remain unclear.
Methods:
We identified all full-text published studies that compared the effects of IVUS-guided CTO-PCI with angiography-guided CTO-PCI by searching electric databases including PubMed, Embase, Cochrane Library, and ISI Web of Science from the establishment to Nov 2021. There was no language limitation. The endpoints included the incidence of major adverse cardiac events (MACE), cardiac death, all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR).
Results:
Five studies involving a total of 2320 patients were included in this meta-analysis. Compared to the angiography-guided group, IVUS-guided PCI showed no significant reduction in the incidence of MACE (I 2 = 27.4%, P = 0.239; RR 0.929, 95% CI 0.765 to 1.128, P = 0.457), cardiac death (I 2 = 0.0%, P = 0.459; RR 0.574, 95% CI 0.299 to 1.103, P = 0.096), all-cause death (I 2 = 0.0%, P = 0.964; RR 0.677, 95% CI 0.395 to 1.163, P = 0.158), MI (I 2 = 46.7%, P = 0.131; RR0.836, 95% CI 0.508 to 1.377, P = 0.482), and TVR (I 2 = 21.2%, P = 0.279; RR 0.929, 95% CI 0.679 to 1.272, P = 0.648).
Conclusions:
IVUS-guided PCI demonstrated no significant benefit on MACE, cardiac death, all-cause death, MI, and TVR in patients with CTO lesions. However, given the study's limitations, additional high-quality RCTs are needed.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations


